Abstract
Nanomedicine formulations are considered to be superior to standard low-molecular-weight drugs because of an increased drug accumulation at the pathological site and a decreased localization to healthy non-target tissues, together leading to an improved balance between the efficacy and the toxicity of (chemo-) therapeutic interventions. To better understand and further improve nanomedicine-mediated drug targeting, it is important to design systems and strategies which are able to provide real-time feedback on the localization, the release and the therapeutic efficacy of these formulations. The advances made over the past few years with regard to the development of novel imaging agents and techniques have provided a broad basis for the design of theranostic nanomedicine materials, i.e. multicomponent carrier constructs in which drugs and imaging agents are combined, and which can be used to address issues related to drug localization, drug release and drug efficacy. Here, we summarize several recent efforts in this regard, and we show that theranostic systems and strategies hold significant potential for monitoring and improving nanomedicine-mediated drug targeting.
Keywords: Drug targeting, image-guided drug delivery, nanomedicine, theranostics, nanomedicine formulations, polymer, biological barriers, toxicity, nanomedicine-mediated drug targeting, drug localization, theranostic systems, low-molecular-weight drugs, novel imaging agents, broad basis, theragnostics
Current Pharmaceutical Biotechnology
Title: Theranostic Systems and Strategies for Monitoring Nanomedicine-Mediated Drug Targeting
Volume: 13 Issue: 4
Author(s): Sijumon Kunjachan, Jabadurai Jayapaul, Marianne E. Mertens, Gert Storm, Fabian Kiessling and Twan Lammers
Affiliation:
Keywords: Drug targeting, image-guided drug delivery, nanomedicine, theranostics, nanomedicine formulations, polymer, biological barriers, toxicity, nanomedicine-mediated drug targeting, drug localization, theranostic systems, low-molecular-weight drugs, novel imaging agents, broad basis, theragnostics
Abstract: Nanomedicine formulations are considered to be superior to standard low-molecular-weight drugs because of an increased drug accumulation at the pathological site and a decreased localization to healthy non-target tissues, together leading to an improved balance between the efficacy and the toxicity of (chemo-) therapeutic interventions. To better understand and further improve nanomedicine-mediated drug targeting, it is important to design systems and strategies which are able to provide real-time feedback on the localization, the release and the therapeutic efficacy of these formulations. The advances made over the past few years with regard to the development of novel imaging agents and techniques have provided a broad basis for the design of theranostic nanomedicine materials, i.e. multicomponent carrier constructs in which drugs and imaging agents are combined, and which can be used to address issues related to drug localization, drug release and drug efficacy. Here, we summarize several recent efforts in this regard, and we show that theranostic systems and strategies hold significant potential for monitoring and improving nanomedicine-mediated drug targeting.
Export Options
About this article
Cite this article as:
Kunjachan Sijumon, Jayapaul Jabadurai, E. Mertens Marianne, Storm Gert, Kiessling Fabian and Lammers Twan, Theranostic Systems and Strategies for Monitoring Nanomedicine-Mediated Drug Targeting, Current Pharmaceutical Biotechnology 2012; 13 (4) . https://dx.doi.org/10.2174/138920112799436302
DOI https://dx.doi.org/10.2174/138920112799436302 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Short Commentary on “Targeting Long Non-Coding RNAs in Nervous System Cancers: New Insights in Prognosis, Diagnosis, and Therapy”
Current Medicinal Chemistry Cancer Chemoprevention by Targeting the Epigenome
Current Drug Targets Antibody-Drug Conjugate Targets
Current Cancer Drug Targets Shaping Tumor Microenvironment for Improving Nanoparticle Delivery
Current Drug Metabolism Neuroblastoma and Stem Cell Therapy: An Updated Review
CNS & Neurological Disorders - Drug Targets The Arrestin Fold: Variations on a Theme
Current Genomics Molecular Biology, Pharmacology and Functional Role of the Plasma Membrane Dopamine Transporter
CNS & Neurological Disorders - Drug Targets Subject Index to Volume 4
Current Medicinal Chemistry - Anti-Cancer Agents <i>DBX2</i> Promotes Glioblastoma Cell Proliferation by Regulating <i>REST</i> Expression
Current Pharmaceutical Biotechnology A Common Biological Mechanism in Cancer and Alzheimers Disease?
Current Alzheimer Research Endocannabinoids and Their Receptors: Physiology, Pathology and Pharmacology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Is the Clinical Use of Cannabis by Oncology Patients Advisable?
Current Medicinal Chemistry Poxvirus Cancer Therapy
Recent Patents on Anti-Infective Drug Discovery Glutamine, Glucose and other Fuels for Cancer
Current Pharmaceutical Design Modulation of Calcium Signaling in Glioblastoma Multiforme: A Therapeutic Promise for Natural Products
Mini-Reviews in Medicinal Chemistry Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance
Current Cancer Drug Targets Animal Venoms have Potential to Treat Cancer
Current Topics in Medicinal Chemistry PEGylated Peptide-Based Imaging Agents for Targeted Molecular Imaging
Current Protein & Peptide Science New Framework for the Discovery of PRC2 Inhibitors: Epigenetic Drugs
Current Drug Targets Nanomedicine against Alzheimer’s and Parkinson’s Disease
Current Pharmaceutical Design